# Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

> **NCT06662162** · NA · RECRUITING · sponsor: **i-Lumen Scientific AUS PTY LTD** · enrollment: 100 (estimated)

## Conditions studied

- Age-Related Macular Degeneration
- Age-related Macular Degeneration (ARMD)
- Intermediate AMD
- Geographic Atrophy Secondary to Age-related Macular Degeneration

## Interventions

- **DEVICE:** i-Lumen AMD

## Key facts

- **NCT ID:** NCT06662162
- **Lead sponsor:** i-Lumen Scientific AUS PTY LTD
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-07
- **Primary completion:** 2027-03-31
- **Final completion:** 2029-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-05-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06662162

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06662162, "Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06662162. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*